Literature DB >> 12042225

Rapid tranquillisation: time for a reappraisal of options for parenteral therapy.

R Hamish McAllister-Williams1, I Nicol Ferrier.   

Abstract

BACKGROUND: When parenteral treatments are indicated for acutely disturbed behaviour, previous guidelines have recommended droperidol or haloperidol in combination with benzodiazepines. However, there has been recent concern over cardiotoxicity and sudden death associated with some antipsychotic medication and droperidol has now been withdrawn. AIMS: To ascertain what alternatives can be recommended to replace intramuscular droperidol.
METHOD: Selective review of current guidelines and the literature pertaining to rapid parenteral tranquillisation.
RESULTS: Current guidelines recommend haloperidol as an alternative to droperidol. There is evidence of cardiotoxicity with haloperidol and it has a propensity to cause extrapyramidal side-effects that may exacerbate disturbed behaviour and reduce longer-term compliance. The rapid-acting intramuscular formulations of atypical antipsychotic agents show promise.
CONCLUSIONS: It is recommended that the mainstay of pharmacological rapid tranquillisation should be parenteral benzodiazepines used with due care.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042225     DOI: 10.1192/bjp.180.6.485

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  11 in total

Review 1.  Haloperidol plus promethazine for psychosis-induced aggression.

Authors:  Gisele Huf; Jacob Alexander; Pinky Gandhi; Michael H Allen
Journal:  Cochrane Database Syst Rev       Date:  2016-11-25

Review 2.  The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs.

Authors:  Guy Chouinard
Journal:  J Psychiatry Neurosci       Date:  2006-05       Impact factor: 6.186

3.  Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine.

Authors: 
Journal:  BMJ       Date:  2003-09-27

4.  Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine.

Authors:  Gisele Huf; E S F Coutinho; C E Adams
Journal:  BMJ       Date:  2007-10-22

5.  Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine.

Authors:  Nirmal S Raveendran; Prathap Tharyan; Jacob Alexander; Clive Elliot Adams
Journal:  BMJ       Date:  2007-10-22

Review 6.  [Psychopharmacological treatment in the pre-clinical emergency medicine].

Authors:  F-G Pajonk; B Fleiter
Journal:  Anaesthesist       Date:  2003-07-10       Impact factor: 1.041

7.  Behavioral emergencies in India: a population based epidemiological study.

Authors:  Sahoo Saddichha; Pandey Vibha; Mukul Kumar Saxena; Mithilesh Methuku
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-07-28       Impact factor: 4.328

8.  A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation.

Authors:  Theodore D Satterthwaite; Daniel H Wolf; Robert A Rosenheck; Raquel E Gur; Stanley N Caroff
Journal:  J Clin Psychiatry       Date:  2008-12-02       Impact factor: 4.384

9.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome.

Authors:  Heng Luo; Jian Chen; Leming Shi; Mike Mikailov; Huang Zhu; Kejian Wang; Lin He; Lun Yang
Journal:  Nucleic Acids Res       Date:  2011-05-10       Impact factor: 16.971

10.  Brazilian guidelines for the management of psychomotor agitation. Part 1. Non-pharmacological approach.

Authors:  Leonardo Baldaçara; Flávia Ismael; Verônica Leite; Lucas A Pereira; Roberto M Dos Santos; Vicente de P Gomes Júnior; Elie L B Calfat; Alexandre P Diaz; Cintia A M Périco; Deisy M Porto; Carlos E Zacharias; Quirino Cordeiro; Antônio Geraldo da Silva; Teng C Tung
Journal:  Braz J Psychiatry       Date:  2018-12-06       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.